Guillain-Barre syndrome following zimeldine treatment. | Zendy

Jan Fagius | Zendy; P. O. Osterman | Zendy; Å Sidén | Zendy; B.E. Wiholm | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Guillain-Barre syndrome following zimeldine treatment.

Author(s) -

Jan Fagius,

P. O. Osterman,

Å Sidén,

B.E. Wiholm

Publication year - 1985

Publication title -

journal of neurology neurosurgery and psychiatry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.391

H-Index - 206

eISSN - 1468-330X

pISSN - 0022-3050

DOI - 10.1136/jnnp.48.1.65

Subject(s) - guillain barre syndrome , medicine , incidence (geometry) , complication , drug , pediatrics , psychiatry , surgery , physics , optics

Thirteen cases of the Guillain-Barré syndrome are reviewed, all occurring with a similar relationship to recent commencement of treatment with the antidepressive drug zimeldine. The risk of developing Guillain-Barré syndrome was increased about 25-fold among patients receiving zimeldine, as compared with the natural incidence of the disorder. The cases described provide strong evidence that Guillain-Barré syndrome may occur as a specific, probably immunologically mediated, complication of drug therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research